← All cap tiers
Cap tier

Micro Cap

Every analyzed stock in Micro Cap — 3,138 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
LABT
Lakewood-Amedex Biotherapeutics Inc.
Valuation N/A
Healthcare
Price$0.78
Model IV—
P/IV—
Limited data — see page
LAFA
LaFayette Acquisition Corp.
Valuation N/A
Financial Services
Price$10.18
Model IV—
P/IV—
Limited data — see page
LAFAR
LaFayette Acquisition Corp.
Valuation N/A
Financial Services
Price$0.07
Model IV—
P/IV—
Limited data — see page
LAFAU
LaFayette Acquisition Corp.
Valuation N/A
Financial Services
Price$10.22
Model IV—
P/IV—
Limited data — see page
LAKE
LAKELAND INDUSTRIES INC
Deeply undervalued
Healthcare
Price$9.96
Model IV$34.48
P/IV0.31
Discount 71% Return to IV: +246.4%
Market implies -24.8%/yr vs model +15.0% · below model
LANV
Lanvin Group Holdings Ltd
Valuation N/A
Consumer Cyclical
Price$0.94
Model IV—
P/IV—
Limited data — see page
LARK
LANDMARK BANCORP INC
Valuation N/A
Financial Services
Price$31.16
Model IV—
P/IV—
Limited data — see page
LASE
Laser Photonics Corp
Deeply overvalued
Technology
Price$0.74
Model IV$0.40
P/IV2.13
Premium +86% Return to IV: -46.3%
Market implies +10.5%/yr vs model +18.8% · below model
LATA
Galata Acquisition Corp. II
Valuation N/A
Financial Services
Price$10.21
Model IV—
P/IV—
Limited data — see page
LATAU
Galata Acquisition Corp. II
Valuation N/A
Financial Services
Price$10.30
Model IV—
P/IV—
Limited data — see page
LATAW
Galata Acquisition Corp. II
Valuation N/A
Financial Services
Price$0.22
Model IV—
P/IV—
Limited data — see page
LAW
CS Disco, Inc.
Deeply overvalued
Technology
Price$4.42
Model IV$2.59
P/IV1.64
Premium +70% Return to IV: -41.3%
Market implies +6.0%/yr vs model +8.2% · in line
LAWR
Robot Consulting Co., Ltd.
Valuation N/A
Technology
Price$3.75
Model IV—
P/IV—
Limited data — see page
LBGJ
Li Bang International Corp Inc.
Deeply overvalued
Industrials
Price$1.87
Model IV$1.34
P/IV1.61
Premium +40% Return to IV: -28.6%
Market implies +6.8%/yr vs model +2.0% · above model
LCCC
Lakeshore Acquisition III Corp.
Valuation N/A
Financial Services
Price$10.54
Model IV—
P/IV—
Limited data — see page
LCCCR
Lakeshore Acquisition III Corp.
Valuation N/A
Financial Services
Price$0.14
Model IV—
P/IV—
Limited data — see page
LCCCU
Lakeshore Acquisition III Corp.
Valuation N/A
Financial Services
Price$10.80
Model IV—
P/IV—
Limited data — see page
LCFY
Locafy Ltd
Valuation N/A
Technology
Price$1.74
Model IV—
P/IV—
Limited data — see page
LCFYW
Locafy Ltd
Valuation N/A
Technology
Price$6.65
Model IV—
P/IV—
Market implies +33.8%/yr vs model +6.1% · above model
LCLN
Lincoln International, Inc.
Valuation N/A
Financial Services
Price$24.62
Model IV—
P/IV—
Limited data — see page
LCNB
LCNB CORP
Overvalued
Financial Services
Price$18.52
Model IV$15.24
P/IV1.12
Premium +22% Return to IV: -17.7%
LCUT
LIFETIME BRANDS, INC
Deeply undervalued
Industrials
Price$9.52
Model IV$15.58
P/IV0.56
Discount 39% Return to IV: +63.7%
Market implies -8.1%/yr vs model +2.0% · below model
LDDD
Longduoduo Co Ltd
Valuation N/A
Healthcare
Price$0.51
Model IV—
P/IV—
Market implies +23.4%/yr
LDI
loanDepot, Inc.
Valuation N/A
Financial Services
Price$0.56
Model IV—
P/IV—
Market implies -27.5%/yr
LDP
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc.
Valuation N/A
Unknown
Price$19.17
Model IV—
P/IV—
Limited data — see page
LEDS
SemiLEDs Corp
Deeply undervalued
Technology
Price$2.23
Model IV$3.54
P/IV0.64
Discount 37% Return to IV: +58.7%
Market implies +7.8%/yr vs model +25.0% · below model
LEE
LEE ENTERPRISES, Inc
Valuation N/A
Communication Services
Price$7.61
Model IV—
P/IV—
Market implies +25.4%/yr vs model +0.0% · above model
LEGT
Legato Merger Corp. III
Valuation N/A
Financial Services
Price$9.52
Model IV—
P/IV—
Limited data — see page
LENZ
LENZ Therapeutics, Inc.
Deeply overvalued
Healthcare
Price$3.65
Model IV$0.66
P/IV5.67
Premium +450% Return to IV: -81.8%
Market implies +21.6%/yr vs model +15.0% · above model
LESL
Leslie's, Inc.
Valuation N/A
Consumer Cyclical
Price$0.03
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
LEXX
Lexaria Bioscience Corp.
Valuation N/A
Healthcare
Price$3.32
Model IV—
P/IV—
Market implies +56.8%/yr
LFAC
Leapfrog Acquisition Corp
Valuation N/A
Financial Services
Price$10.08
Model IV—
P/IV—
Limited data — see page
LFACW
Leapfrog Acquisition Corp
Valuation N/A
Financial Services
Price$0.28
Model IV—
P/IV—
Limited data — see page
LFCR
LIFECORE BIOMEDICAL, INC. DE
Deeply overvalued
Healthcare
Price$6.45
Model IV$2.86
P/IV1.75
Premium +125% Return to IV: -55.6%
Market implies +8.0%/yr vs model +6.3% · in line
LFMD
LifeMD, Inc.
Deeply undervalued
Healthcare
Price$2.63
Model IV$5.34
P/IV0.80
Discount 51% Return to IV: +103.0%
Market implies -9.6%/yr vs model +20.2% · below model
LFS
LEIFRAS Co., Ltd.
Deeply overvalued
Consumer Defensive
Price$2.21
Model IV$1.60
P/IV1.35
Premium +38% Return to IV: -27.7%
Market implies +6.4%/yr vs model +5.0% · in line
LFT
Lument Finance Trust, Inc.
Fairly valued
Financial Services
Price$5.17
Model IV$4.93
P/IV0.21
Premium +5% Return to IV: -4.6%
LFVN
Lifevantage Corp
Overvalued
Healthcare
Price$6.00
Model IV$4.63
P/IV1.34
Premium +30% Return to IV: -22.8%
Market implies +6.4%/yr vs model +6.1% · in line
LFWD
Lifeward Ltd.
Deeply undervalued
Healthcare
Price$6.49
Model IV$41.32
P/IV0.17
Discount 84% Return to IV: +536.6%
Market implies -38.7%/yr vs model +38.6% · below model
LGCL
Lucas GC Ltd
Valuation N/A
Technology
Price$2.23
Model IV—
P/IV—
Market implies -50.0%/yr vs model +15.0% · below model
LGCY
Legacy Education Inc.
Deeply undervalued
Consumer Defensive
Price$10.23
Model IV$17.09
P/IV0.65
Discount 40% Return to IV: +67.0%
Market implies +9.6%/yr vs model +25.0% · below model
LGHL
Lion Group Holding Ltd
Valuation N/A
Financial Services
Price$3.10
Model IV—
P/IV—
Limited data — see page
LGI
LAZARD GLOBAL TOTAL RETURN & INCOME FUND INC
Valuation N/A
Unknown
Price$17.10
Model IV—
P/IV—
Limited data — see page
LGL
LGL GROUP INC
Deeply overvalued
Technology
Price$6.83
Model IV$1.57
P/IV4.54
Premium +336% Return to IV: -77.0%
Market implies +8.0%/yr vs model +14.1% · below model
LGN
Legence Corp.
Valuation N/A
Industrials
Price$51.53
Model IV—
P/IV—
Limited data — see page
LGO
Largo Inc.
Deeply overvalued
Basic Materials
Price$0.47
Model IV$0.17
P/IV4.26
Premium +177% Return to IV: -63.9%
Market implies +12.5%/yr vs model +0.0% · above model
LGPS
LOGPROSTYLE INC.
Valuation N/A
Industrials
Price$0.73
Model IV—
P/IV—
Market implies +33.2%/yr vs model +8.0% · above model
LHAI
Linkhome Holdings Inc.
Deeply overvalued
Real Estate
Price$1.01
Model IV$0.76
P/IV1.21
Premium +33% Return to IV: -25.0%
Market implies +19.1%/yr vs model +25.0% · below model
LHSW
Lianhe Sowell International Group Ltd
Valuation N/A
Technology
Price$0.52
Model IV—
P/IV—
Market implies -50.0%/yr
LICN
Lichen International Ltd
Valuation N/A
Industrials
Price$0.95
Model IV—
P/IV—
Market implies +34.8%/yr vs model +2.0% · above model
LIDR
AEye, Inc.
Valuation N/A
Consumer Cyclical
Price$1.04
Model IV—
P/IV—
Market implies +43.0%/yr vs model +8.0% · above model
LIDRW
LIDRW
Valuation N/A
Price$0.00
Model IV—
P/IV—
Limited data — see page
LIEN
Chicago Atlantic BDC, Inc.
Valuation N/A
Unknown
Price$9.27
Model IV—
P/IV—
Limited data — see page
LIMN
Liminatus Pharma, Inc.
Valuation N/A
Healthcare
Price$3.76
Model IV—
P/IV—
Limited data — see page
LIMNW
Liminatus Pharma, Inc.
Valuation N/A
Healthcare
Price$0.05
Model IV—
P/IV—
Limited data — see page
LINK
INTERLINK ELECTRONICS INC
Deeply overvalued
Technology
Price$4.95
Model IV$1.38
P/IV3.90
Premium +259% Return to IV: -72.2%
Market implies +17.8%/yr vs model +12.3% · above model
LIQT
LIQTECH INTERNATIONAL INC
Deeply overvalued
Industrials
Price$0.41
Model IV$0.28
P/IV2.49
Premium +47% Return to IV: -32.0%
Market implies -0.8%/yr vs model +2.0% · in line
LITS
Lite Strategy, Inc.
Valuation N/A
Healthcare
Price$1.27
Model IV—
P/IV—
Market implies -20.5%/yr vs model +15.0% · below model
LIVE
LIVE VENTURES Inc
Deeply undervalued
Consumer Cyclical
Price$7.65
Model IV$80.07
P/IV0.13
Discount 90% Return to IV: +946.7%
Market implies -32.5%/yr vs model +11.5% · below model
LIXT
LIXT
Valuation N/A
Price$3.66
Model IV—
P/IV—
Limited data — see page